Literature DB >> 27664953

Associations of the Serum/Glucocorticoid Regulated Kinase Genes With BP Changes and Hypertension Incidence: The Gensalt Study.

Dingding Zhang1,2, Dongfeng Gu1, Jiang He2, James E Hixson3, Dabeeru C Rao4, Changwei Li2, Hua He2, Jichun Chen1, Jianfeng Huang1, Jing Chen2, Treva K Rice4, Shufeng Chen1, Tanika N Kelly5.   

Abstract

BACKGROUND: Single-marker and novel gene-based methods were employed to examine the associations of the serum/glucocorticoid regulated kinases (SGK) gene family with longitudinal blood pressure (BP) changes and hypertension incidence in a family-based cohort study.
METHODS: Totally, 1,768 Chinese participants from the Genetic Epidemiology Network of Salt Sensitivity (GenSalt) follow-up study were included in the current analyses. Nine BP measures were obtained at each of 3 visits during the GenSalt follow-up study. Mixed-model and Gene-based analyses were used to examine the associations of the SGK gene family with longitudinal BP phenotypes. Bonferroni correction was applied to account for multiple testing.
RESULTS: After an average 7.2-year follow-up, 32.2% (513) of participants free of hypertension at baseline developed hypertension. Four novel SNPs in the SGK1 gene were predictive of the longitudinal BP phenotypes. The major alleles of SGK1 rs1763498 and rs114414980 conferred 2.9- and 2.5-fold increased risks of hypertension development, respectively (P = 1.0×10-4 and 6.0×10-4, respectively). In addition, the major allele of SGK1 rs229133 was significantly associated with 0.4mm Hg larger annual increases in systolic BP (P = 4.2×10-4), while the major allele of rs6924468 was significantly associated with 0.2mm Hg smaller annual increases in diastolic BP (P = 4.2×10-4). Gene-based analyses revealed an association of the SGK1 gene with risk of hypertension development (P = 7.4×10-3). No evidence for the SGK2 and SGK3 genes was found.
CONCLUSIONS: The findings of the current study suggest that the SGK1 gene may play a role in long-term BP regulation and hypertension incidence. © American Journal of Hypertension, Ltd 2016. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  SGK; blood pressure; blood pressure changes; common variants; hypertension.

Mesh:

Substances:

Year:  2016        PMID: 27664953      PMCID: PMC5155568          DOI: 10.1093/ajh/hpw122

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  35 in total

1.  Impaired renal Na(+) retention in the sgk1-knockout mouse.

Authors:  Peer Wulff; Volker Vallon; Dan Yang Huang; Harald Völkl; Fang Yu; Kerstin Richter; Martina Jansen; Michaela Schlünz; Karin Klingel; Johannes Loffing; Gunther Kauselmann; Michael R Bösl; Florian Lang; Dietmar Kuhl
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

3.  The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action.

Authors:  A Bhargava; M J Fullerton; K Myles; T M Purdy; J W Funder; D Pearce; T J Cole
Journal:  Endocrinology       Date:  2001-04       Impact factor: 4.736

4.  SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells.

Authors:  Yuanzhong Wang; Dujin Zhou; Sheryl Phung; Selma Masri; David Smith; Shiuan Chen
Journal:  Mol Endocrinol       Date:  2010-11-17

Review 5.  High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs.

Authors:  Samantha Bromfield; Paul Muntner
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

6.  Targeted disruption of the protein kinase SGK3/CISK impairs postnatal hair follicle development.

Authors:  James A McCormick; Yuxi Feng; Kevin Dawson; Martin J Behne; Benjamin Yu; Jian Wang; Amanda W Wyatt; Guido Henke; Florian Grahammer; Theodora M Mauro; Florian Lang; David Pearce
Journal:  Mol Biol Cell       Date:  2004-07-07       Impact factor: 4.138

7.  Renal function of gene-targeted mice lacking both SGK1 and SGK3.

Authors:  Florian Grahammer; Ferruh Artunc; Diana Sandulache; Rexhep Rexhepaj; Björn Friedrich; Teut Risler; James A McCormick; Kevin Dawson; Jian Wang; David Pearce; Peer Wulff; Dietmar Kuhl; Florian Lang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-04       Impact factor: 3.619

8.  [Prevalence of hypertension among Chinese adults in 2010].

Authors:  Yi-chong Li; Li-min Wang; Yong Jiang; Xiao-yan Li; Mei Zhang; Nan Hu
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2012-05

Review 9.  Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases.

Authors:  D Lauro; D Pastore; B Capuani; F Pacifici; R Palmirotta; P Abete; M Roselli; A Bellia; M Federici; N Di Daniele; P Sbraccia; F Guadagni; R Lauro; D Della-Morte
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

10.  Serum- and glucocorticoid-induced kinase 3 in recycling endosomes mediates acute activation of Na+/H+ exchanger NHE3 by glucocorticoids.

Authors:  Peijian He; Sei-Jung Lee; Songbai Lin; Ursula Seidler; Florian Lang; Geza Fejes-Toth; Aniko Naray-Fejes-Toth; C Chris Yun
Journal:  Mol Biol Cell       Date:  2011-08-24       Impact factor: 4.138

View more
  1 in total

Review 1.  Genetics of Human Primary Hypertension: Focus on Hormonal Mechanisms.

Authors:  Worapaka Manosroi; Gordon H Williams
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.